EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 14 November 2024

Despite a decade of gradual growth, R&D spending in Europe outpaced by the US – with increasing competition from China, new data shows

Access the full report here.

New research published by EFPIA provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across Member States and compares Europe to other regions of the world.

The research shows that EU pharmaceutical R&D spending grew on average 4.4% per year between 2010 and 2022, from €27.8 billion to €46.2 billion.

However, the data also provides further warning of the divergence in R&D spending between the EU and the other parts of the world, as Europe fails to keep pace with the growth seen in the sector in Asia and the US.

INNODIA: A Success Story in Type 1 Diabetes Research and Treatment
14 November 2024 - Sanjoy Dutta - Carmen Hurtado del Pozo

Type 1 Diabetes (T1D) is an autoimmune disease where the body’s own immune system mistakenly attacks insulin-producing... Read more

Filling the Gaps in Care: Driving Change through Embracing Carers®
13 November 2024 - Marieta Jiménez Urgal

Supporting informal carers isn’t just about helping; it’s about elevating entire communities. Read more

Navigating Certainty and Analytical Complexity: Industry’s Reflections on Ensuring Scientific...
10 November 2024 - Antonia Morga - Katrin Kupas - Agnes Kisser

The HTA Regulation (HTAR) requires that Joint Clinical Assessments (JCAs) describe the certainty of a health technology’s... Read more

EFPIA Conference – Registration is open!

Join leaders from the pharmaceutical industry, policymakers, patient advocates, and healthcare experts to discuss how we can work together to build a healthier, more competitive Europe.

Events

Marie Skłodowska-Curie Actions (MSCA) Staff Exchanges Information Session
15 November 2024 (Virtual event)

Join the web-based information session on 15 November 2024 where the European Research Executive Agency (REA) will provide... Read more

Antimicrobial resistance is invisible, I am not
18 November 2024 (Virtual event)

Organised by the European Centre for Disease Prevention and Control Read more

Rare Disease Moonshot event

How can public-private collaboration accelerate research in rare diseases?

Watch the Euronews debate to find out more.

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu